QQ客服 官方微博 反馈留言

	IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway
	Gao Li; Han Haige; Wang Honglei; Cao Li; Feng Wen-Hai
	2019
卷号	462页码:12-22
关键词	EBV reactivation EBV-Associated tumors IL-10 silencing VEGF
ISSN号	1872-7980
DOI	10.1016/j.canlet.2019.07.016
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6339049
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Gao Li,Han Haige,Wang Honglei,et al. IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway[J],2019,462:12-22.
APA	Gao Li,Han Haige,Wang Honglei,Cao Li,&Feng Wen-Hai.(2019).IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway.,462,12-22.
MLA	Gao Li,et al."IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway".462(2019):12-22.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。